Aggregated News From Investment Management Regulators

Press release on the suspension of trading in Acacia Pharma

Report/Flag

Please complete the required fields.



ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017

Trading in the financial instruments of Acacia Pharma, ISIN GB00BYWF9Y76, on Euronext Brussels is suspended on the request of the company from 13/08/2020 at 14:45 CET until the publication of a press release.

Source link

Regulator Information

Abbreviation: FSMA
Jurisdiction: Belgium

Recent Articles

Remediation Helps Tech Company Avoid Penalties

SEC’s fraud case against Silicon Valley-based HeadSpin, Inc.’s former CEO is ongoing Washington D.C., Jan.

SuperiorCryptoTrade

We believe this firm may be providing financial services or products in the UK without our authorisation. Find out why you should be wary...

Berge and Associates LLC

We believe this firm may be providing financial services or products in the UK without our authorisation. Find out why you should be wary...

SwiftCryptoLimited

We believe this firm may be providing financial services or products in the UK without our authorisation. Find out why you should be wary...

Get the latest from Regulatory.News in your inbox!

×